Cover Image

Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment

Abstract Background The Global Program for the Elimination of Lymphatic Filariasis (GPELF) started operation in 2000 and aimed at eliminating the disease by the year 2020, following 5-6 rounds of effective annual Mass Drug Administration (MDA). The MDA programme took off in Ghana in 2001 and has int...

Full description

Saved in:

Bibliographic Details
Main Authors:	Collins S. K. Ahorlu (Author), Eric Koka (Author), Susan Adu-Amankwah (Author), Joseph Otchere (Author), Dziedzom Komi de Souza (Author)
Format:	Book
Published:	BMC, 2018-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectors
by: Sellase Pi-Bansa, et al.
Published: (2019)

Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana.
by: Derrick Adu Mensah, et al.
Published: (2022)

Spatial variation in lymphatic filariasis risk factors of hotspot zones in Ghana
by: Efiba Vidda Senkyire Kwarteng, et al.
Published: (2021)

Assessing Lymphatic Filariasis Data Quality in Endemic Communities in Ghana, Using the Neglected Tropical Diseases Data Quality Assessment Tool for Preventive Chemotherapy.
by: Dziedzom K de Souza, et al.
Published: (2016)

Knowledge and perceptions of lymphatic filariasis patients in selected hotspot endemic communities in southern Ghana.
by: Alexander Kwarteng, et al.
Published: (2023)

Knowledge and perceptions of lymphatic filariasis patients in selected hotspot endemic communities in southern Ghana
by: Alexander Kwarteng, et al.
Published: (2023)

Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
by: Dziedzom K de Souza, et al.
Published: (2020)

Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.
by: Colleen L Lau, et al.
Published: (2017)

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017)

Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis.
by: Julie R Harris, et al.
Published: (2017)

Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
by: Helen J Mayfield, et al.
Published: (2024)

The development of a capacity-strengthening program to promote self-care practices among people with lymphatic filariasis-related lymphedema in the Upper West Region of Ghana
by: Solomon Abotiba Atinbire, et al.
Published: (2021)

Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?
by: Maria P Rebollo, et al.
Published: (2015)

Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicators.
by: Nana-Kwadwo Biritwum, et al.
Published: (2017)

Evaluating the availability and quality of services for lymphatic filariasis morbidity in Ghana.
by: Melissa Edmiston, et al.
Published: (2023)

Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
by: Subramanian Swaminathan, et al.
Published: (2012)

Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
by: Pramod Kumar Mehta, et al.
Published: (2024)

Assessment of transmission in areas of uncertain endemicity for lymphatic filariasis in Brazil.
by: Amanda Xavier, et al.
Published: (2019)

An empirical analysis of the effects of schistosomiasis and lymphatic filariasis on macroeconomic output in Ghana
by: Mustapha Immurana, et al.
Published: (2024)

Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone.
by: Joseph B Koroma, et al.
Published: (2013)

The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar.
by: Benjamin F R Dickson, et al.
Published: (2018)

Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis.
by: Molly A Brady, et al.
Published: (2017)

Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
by: Corrado Minetti, et al.
Published: (2019)

Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods.
by: Kinley Wangdi, et al.
Published: (2022)

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
by: Paul E Simonsen, et al.
Published: (2010)

Long-lasting insecticidal nets are synergistic with mass drug administration for interruption of lymphatic filariasis transmission in Nigeria.
by: Abel Eigege, et al.
Published: (2013)

Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
by: Ramakrishna U Rao, et al.
Published: (2017)

No evidence for lymphatic filariasis transmission in big cities affected by conflict related rural-urban migration in Sierra Leone and Liberia.
by: Dziedzom K de Souza, et al.
Published: (2014)

Towards elimination of lymphatic filariasis in southeastern Madagascar: Successes and challenges for interrupting transmission.
by: Andres Garchitorena, et al.
Published: (2018)

First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
by: Hugues C Nana-Djeunga, et al.
Published: (2017)

Lymphatic Filariasis in Sri Lanka
by: C. Harriet Gautamadasa
Published: (2001)

Elimination of lymphatic filariasis in the Gambia.
by: Maria P Rebollo, et al.
Published: (2015)

Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
by: Dung D Pam, et al.
Published: (2017)

Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.
by: Brian K Chu, et al.
Published: (2013)

Secondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settings.
by: Naomi Drexler, et al.
Published: (2012)

Lymphatic filariasis transmission on Mafia Islands, Tanzania: Evidence from xenomonitoring in mosquito vectors.
by: Yahya A Derua, et al.
Published: (2017)

Lymphatic filariasis, infection status in Culex quinquefasciatus and Anopheles species after six rounds of mass drug administration in Masasi District, Tanzania
by: Eliza Lupenza, et al.
Published: (2021)

Impact of mass drug administration for elimination of lymphatic filariasis in Nepal.
by: Chet Raj Ojha, et al.
Published: (2017)

National mass drug administration costs for lymphatic filariasis elimination.
by: Ann S Goldman, et al.
Published: (2007)

Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
by: Ramakrishna U Rao, et al.
Published: (2019)